Pulling FMCSA records…

Burlington Drug Company INC (USDOT 40359)

No blockers or cautions found.

Operating authority
No active operating authority on file with FMCSA.
Insurance on file
No active liability (BIPD) insurance on file with FMCSA.
Safety rating
Satisfactory (rating decision 2008-06-02)
Fleet on file
5 power units, 3 drivers
Operation type
Interstate
Physical address
91 CATAMOUNT DRIVE, MILTON, VT 05468
MCS-150 last filed
2025-11

Findings

  • Safety rating is more than 5 years old (Caution): Last rated 2008-06-02 (18 years ago) — rating is two audit cycles old and no longer a reliable current-state signal

Frequently asked questions

What carrier is USDOT 40359?

USDOT 40359 is Burlington Drug Company INC, an interstate motor carrier.

What is Burlington Drug Company INC's USDOT number?

Burlington Drug Company INC's USDOT number is 40359. No MC docket number is on file.

Is Burlington Drug Company INC currently authorized to operate?

No active operating authority on file with FMCSA. Source: FMCSA registration and licensing records.

Does Burlington Drug Company INC have insurance on file with FMCSA?

No active liability (BIPD) insurance on file with FMCSA.

What is Burlington Drug Company INC's safety record?

In the last 24 months, FMCSA records show 4 roadside inspections with a 25.0% vehicle out-of-service rate (national average 22.7%) and 0 recordable crashes.

What is Burlington Drug Company INC's CSA score?

FMCSA does not publish a single CSA score for carriers. Burlington Drug Company INC's public safety data includes its roadside inspection out-of-service rates and crash record, listed on this page.

What is Burlington Drug Company INC's FMCSA safety rating?

Burlington Drug Company INC's FMCSA safety rating is Satisfactory, from a review decided 2008-06-02.

View the full fleetfax report for Burlington Drug Company INC

Reconstructed from cached and fleetfax-ingested FMCSA public records (live FMCSA was unavailable) — may be out of date; verify current status on FMCSA SAFER. fleetfax surfaces the facts; brokers make the judgment.